Skip to content
Hims & Hers Health logo

Hims & Hers Health

HIMS

Hims & Hers Health, Inc. operates a consumer-first digital health platform that provides access to personalized medical treatments and wellness products.

Market cap
$7B-52.3%
Revenue$2.4B+32.8%
Net income-$13.2M-108%
Free cash flow$282.3M-10.7%
EPS (diluted)-$0.09-113%
Trailing twelve months · change vs. prior year

Earnings

Next report

Aug 10, 2026 (In 1 week)
Revenue estimate$698.9M
EPS estimate-$0.07

Financials

Q1 2026

Income statement

See full
Revenue$608.1M+3.8%
Gross profit$396.8M-7.9%
Operating income-$78.3M-235%
Net income-$92.1M-286%
EPS (diluted)-$0.40-300%

Balance sheet

See full
Cash & equivalents$222.3M-19.2%
Total debt$157.9M+149%
Total equity$446.2M-18.8%
Total assets$2.3B+154%

Cash flow

See full
Operating cash flow$89.4M-18.1%
CapEx$8.8M-19.9%
Free cash flow$80.5M-17.9%

Valuation & ratios

Valuation

See full
Market cap$7B-52.3%
Enterprise value$6.93B-42.6%
P/S-3.6×

Profitability

See full
Gross margin71.7%-5.3pp
Operating margin-1.3%-7.5pp
Net margin-0.6%-9.8pp
FCF margin11.9%-5.8pp

Returns & leverage

See full
Return on equity-2.7%-39.4pp
Debt / equity0.4×+0.2×
Current ratio1.7×+0.1×

Segments

By geography

See full
Non-US$78.2M+969%

Competitors

Profile

Hims & Hers Health, Inc. operates a consumer-first digital health platform that provides access to personalized medical treatments and wellness products. The company integrates a provider network, electronic medical records, and cloud-based pharmacy fulfillment to facilitate telehealth consultations and recurring delivery of prescription and non-prescription solutions. Its core value proposition centers on reducing the stigma and accessibility barriers associated with chronic conditions through a seamless, brand-driven digital experience.

Competitive position

A leading digital health platform focused on normalizing treatment for stigmatized conditions through a vertically integrated technology and pharmacy stack.

GeographiesUnited States, United Kingdom, Canada, European Union, Australia
Customer segmentsB2C, Patients
Business modelDirect-to-Consumer, Subscription, E-commerce, Marketplace
SuppliersPharmaceutical manufacturers, Raw material suppliers for compounding, Contract manufacturers, Cloud infrastructure providers
CustomersIndividual retail consumers, Subscription members, Brick-and-mortar retail partners
Listed2021
Employees1.0K
CEOAndrew Dudum
FilingsSEC EDGAR

Questions, answered.

What is Hims & Hers Health's market cap?
Hims & Hers Health (HIMS) has a market capitalization of $7.0B and trades on NYSE.
What is Hims & Hers Health's revenue and profitability?
Hims & Hers Health generated $2.4B in trailing twelve-month revenue with a net loss of $13.2M, representing a net margin of -0.6%. Gross margin stands at 71.7%, with free cash flow of $282.3M. These figures are based on the Q1 2026 filing.
Who are Hims & Hers Health's competitors?
Hims & Hers Health's key competitors include Teladoc Health, Amazon Pharmacy, Prestige Consumer Healthcare Inc., and others. These companies compete in similar markets and product categories.
Who does Hims & Hers Health partner with?
Hims & Hers Health's notable partners include Eucalyptus.
Where is Hims & Hers Health headquartered?
Hims & Hers Health is headquartered in United States of America and employs approximately 1,046 people. It has been publicly traded since 2021.